Halozyme Therapeutics Inc (HALO)
49.00
+3.30
(+7.22%)
USD |
NASDAQ |
Nov 22, 16:00
48.52
-0.48
(-0.98%)
After-Hours: 20:00
Halozyme Therapeutics Cash from Investing (Quarterly): -167.48M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -167.48M |
| June 30, 2024 | -42.04M |
| March 31, 2024 | -82.68M |
| December 31, 2023 | -8.291M |
| September 30, 2023 | -83.45M |
| June 30, 2023 | 54.99M |
| March 31, 2023 | -60.16M |
| December 31, 2022 | -1.746M |
| September 30, 2022 | -1.008M |
| June 30, 2022 | -434.95M |
| March 31, 2022 | -49.30M |
| December 31, 2021 | -299.47M |
| September 30, 2021 | -16.95M |
| June 30, 2021 | -44.62M |
| March 31, 2021 | -45.25M |
| December 31, 2020 | 58.44M |
| September 30, 2020 | -30.10M |
| June 30, 2020 | 11.90M |
| March 31, 2020 | 38.11M |
| December 31, 2019 | -122.82M |
| September 30, 2019 | 41.00M |
| June 30, 2019 | 47.46M |
| March 31, 2019 | 28.81M |
| December 31, 2018 | 10.81M |
| September 30, 2018 | 35.19M |
| Date | Value |
|---|---|
| June 30, 2018 | -7.607M |
| March 31, 2018 | -35.90M |
| December 31, 2017 | -148.99M |
| September 30, 2017 | 30.28M |
| June 30, 2017 | -49.29M |
| March 31, 2017 | 4.265M |
| December 31, 2016 | 21.04M |
| September 30, 2016 | 8.246M |
| June 30, 2016 | -0.435M |
| March 31, 2016 | -105.62M |
| December 31, 2015 | -14.76M |
| September 30, 2015 | 20.29M |
| June 30, 2015 | 10.77M |
| March 31, 2015 | -10.42M |
| December 31, 2014 | 13.48M |
| September 30, 2014 | 2.628M |
| June 30, 2014 | -5.87M |
| March 31, 2014 | -43.19M |
| December 31, 2013 | 2.017M |
| September 30, 2013 | -0.325M |
| June 30, 2013 | -0.08M |
| March 31, 2013 | -49.48M |
| December 31, 2012 | -0.5398M |
| September 30, 2012 | -0.1675M |
| June 30, 2012 | -0.7215M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-434.95M
Minimum
Jun 2022
58.44M
Maximum
Dec 2020
-66.34M
Average
-43.33M
Median
Cash from Investing (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 53.47M |
| Novavax Inc | 31.91M |
| Kura Oncology Inc | 45.54M |
| TransMedics Group Inc | -47.76M |
| Pulmonx Corp | 6.751M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 115.38M |
| Cash from Financing (Quarterly) | 18.56M |
| Free Cash Flow | 392.71M |
| Free Cash Flow Per Share (Quarterly) | 0.8749 |
| Free Cash Flow to Equity (Quarterly) | 112.22M |
| Free Cash Flow to Firm (Quarterly) | 117.61M |
| Free Cash Flow Yield | 6.17% |